Event 
Medical 
Corporate 
2018-09-06
Hong Kong is Actively Building Technology Platform
Mr. Eddie Liu, Managing Director of ACT Genomics Hong Kong was invited to give a talk to share the experience of ACT Genomics expanding from Taiwan to Hong Kong.
Published:
Taipei
Author(s):
2018-08-27
The Trend Toward Intelligent Biomedical Industry – Taipei Biotechnology Industry Summit
The Taipei Biotechnology Industry Summit was held in Taipei on August 27th by Department of Economic Development, Taipei City Government. ACT Genomics CEO, Dr. Hua-Chien Chen shared ”cancer precision medicine and its clinical application”. Dr. Chen said
Published:
Taipei
Author(s):
2018-06-15
ACT Genomics Shared Cutting-Edge Technology in Taiwan Bio Forum
ACT Genomics was invited to Taiwan Bio Forum, which was held in Harvard Medical School in USA this year. As the first speaker, ACT Genomics shared cutting-edge technology application in cancer management and precision medicine.
Published:
Author(s):
2018-06-06
Taiwan Bio Forum on digital transformation in healthcare
ACT Genomics is honoured to introduce precision medicine in Taiwan Bio Forum co-organized by The Development Center for Biotechnology (DCB) and Monte Jade Science and Technology Association of New England (MJNE) in Boston.
Published:
Author(s):
2018-05-10
Gene Online reports on 2018 TJCC (Taiwan Joint Cancer Conference)
Dr. Sadakatsu Ikeda, ACTG's guest speaker at TJCC, shared his insights on when to use mono-therapy, combine-therapy, and immuno-therapy, using genomic profiling and tumor mutation burden (TMB) as guidance.
Published:
Taipei
Author(s):
2017-11-01
Immunotherapy in Cancer Management... Are we Ready?
Co-organized with Singapore’s College of Clinician Scientists, the seminar themed Immunotherapy in cancer management …Are We Ready? took place on September 19, 2017, in Singapore, ACT Genomics Chief Scientific Officer, Dr.? Shu Jen Chen delivered a talk o
Published:
biotechin
Author(s):
